Search results
Dec 26, 2023 · Sarcoidosis is a multisystem disorder of unknown etiology characterized by the formation of inflammatory non-caseating granulomas within affected tissues. Histologically, the lesions characteristically demonstrate an absence of a necrotic component, except in rare cases (so-called "necrotizing sarcoid granulomatosis").
Jun 5, 2024 · Both chest radiograph and CT are commonly used to evaluate for thoracic sarcoidosis. Imaging evaluation can be tricky, as the manifestations are variable and depend on the stage of disease on both x-ray and CT 1-3.
Jul 11, 2018 · Sarcoidosis is a multisystem granulomatous disorder characterized by development of noncaseating granulomas in various organs. Although the etiology of this condition is unclear, environmental and genetic factors may be substantial in its pathogenesis.
Aug 19, 2022 · Sarcoidosis is a systemic inflammatory disease of unknown origin characterized by the formation of non-caseating granulomas. Virtually any organ system may be involved.
Oct 6, 2010 · Abstract. Typical and atypical CT manifestations in biopsy-proved cases of pulmonary sarcoidosis are reviewed, with emphasis on differential diagnosis, potential imaging pitfalls, and radiologic pathologic correlation.
Oct 31, 2019 · Although some radiographic and CT findings are typical for sarcoidosis, sarcoidosis cannot be diagnosed purely based on imaging and requires complete clinical and pathologic correlation for definitive diagnosis.
Aug 17, 2018 · Although fluorine 18 fluorodeoxyglucose PET/CT is not included in the standard workup of sarcoidosis, there is growing evidence to support the value of this examination for assessing inflammatory activity and guiding diagnosis and management.
This article will review the typical and atypical imaging features of sar- coidosis, identify entities that may be mistaken for sarcoidosis, and discuss patterns and clini - cal scenarios that suggest an alternative diagnosis.
Case Discussion. This is the II stage of sarcoidosis as both nodal and parenchymal involvement is present. Nearly 90% of patients present with pulmonary manifestations. Patients between the ages of 20 and 40 are most often affected.
A diagnosis of probable neurosarcoidosis can be based on clinical or imaging evidence of lesions, with evidence of systemic sarcoidosis obtained from a biopsy of another organ or positive results on a Kveim test , which is performed by intradermal injection of homogenized spleen or liver from a patient with known sarcoidosis. The test result is ...
